\begin{table}[htbp]\centering\begin{tabular}{lccc}\hline
Characteristic & Good Outcome & Poor Outcome & P-value \\
\hline
Number of patients & 2027 & 1927 & \\

\makecell[l]{Outcome} & $25.37 \pm 25.09$ & $604.32 \pm 437.04$ & 0.000 $\uparrow$ \\

\makecell[l]{Gender} & 0: 64.7\%, 1: 35.3\% & 0: 61.1\%, 1: 38.9\% & 0.023  \\

\makecell[l]{First Visit Age} & $30.12 \pm 21.79$ & $28.11 \pm 23.61$ & 0.005 $\downarrow$ \\

\makecell[l]{CI nd U} & 0: 99.3\%, 1: 0.7\% & 0: 97.2\%, 1: 2.8\% & 0.000  \\

\makecell[l]{Lymphocytes Percentage} & $28.98 \pm 14.05$ & $34.02 \pm 13.88$ & 0.000 $\uparrow$ \\

\makecell[l]{Neutrophils Percentage} & $63.13 \pm 15.68$ & $56.63 \pm 14.97$ & 0.000 $\downarrow$ \\

\makecell[l]{Monocytes Percentage} & $6.18 \pm 1.64$ & $6.49 \pm 1.67$ & 0.000 $\uparrow$ \\

\makecell[l]{Mean Corpuscular \\ Hemoglobin \\ Concentration} & $335.62 \pm 10.51$ & $336.93 \pm 10.30$ & 0.000 $\uparrow$ \\

\makecell[l]{Platelet Count} & $263.47 \pm 74.09$ & $256.73 \pm 68.96$ & 0.003 $\downarrow$ \\

\makecell[l]{White Blood Cell Count} & $10.31 \pm 3.00$ & $9.35 \pm 2.39$ & 0.000 $\downarrow$ \\

\makecell[l]{Mean Corpuscular \\ Hemoglobin} & $29.07 \pm 2.33$ & $28.98 \pm 2.30$ & 0.202  \\

\makecell[l]{Mean Corpuscular Volume} & $86.66 \pm 6.65$ & $85.99 \pm 6.67$ & 0.002 $\downarrow$ \\

\makecell[l]{Hemoglobin} & $130.03 \pm 9.16$ & $130.20 \pm 8.46$ & 0.546  \\

\makecell[l]{Eosinophils Percentage} & $1.55 \pm 2.02$ & $2.31 \pm 2.37$ & 0.000 $\uparrow$ \\

\makecell[l]{Basophils Percentage} & $0.25 \pm 0.22$ & $0.32 \pm 0.24$ & 0.000 $\uparrow$ \\

\makecell[l]{Absolute Eosinophil \\ Count} & $0.13 \pm 0.20$ & $0.18 \pm 0.21$ & 0.000 $\uparrow$ \\

\makecell[l]{Absolute Lymphocyte \\ Count} & $2.61 \pm 1.12$ & $2.83 \pm 1.29$ & 0.000 $\uparrow$ \\

\makecell[l]{Mean Platelet Volume} & $9.14 \pm 1.39$ & $9.02 \pm 1.39$ & 0.007 $\downarrow$ \\

\makecell[l]{Platelet Distribution \\ Width} & $12.72 \pm 1.96$ & $12.57 \pm 1.94$ & 0.020 $\downarrow$ \\

\makecell[l]{Eosinophil Count \\ Absolute} & $128.60 \pm 141.68$ & $162.83 \pm 190.02$ & 0.000 $\uparrow$ \\

\makecell[l]{CR eactive Protein} & $13.03 \pm 19.62$ & $7.71 \pm 10.23$ & 0.000 $\downarrow$ \\

\makecell[l]{Immunoglobulin E} & $131.65 \pm 242.00$ & $152.28 \pm 346.75$ & 0.029 $\uparrow$ \\

\makecell[l]{SMRNP} & $1.18 \pm 2.16$ & $1.22 \pm 1.84$ & 0.576  \\

\makecell[l]{Anti SSA} & $1.42 \pm 5.44$ & $1.58 \pm 5.68$ & 0.363  \\

\makecell[l]{Anti Jo 1} & $1.08 \pm 1.77$ & $1.12 \pm 2.06$ & 0.534  \\

\makecell[l]{Nucleosome} & $0.57 \pm 0.34$ & $0.65 \pm 0.43$ & 0.000 $\uparrow$ \\

\makecell[l]{Ribosomal PP rotein} & $1.07 \pm 0.71$ & $1.17 \pm 2.13$ & 0.050  \\

\makecell[l]{Ro 52} & $2.10 \pm 5.90$ & $2.23 \pm 6.81$ & 0.515  \\
\hline\end{tabular}\caption{Comparison of the characteristics between patients with good and poor outcomes in the time independent dataset \\ continuous variables are presented as mean Â± standard deviation, categorical variables are presented as number (percentage) \\ good outcome is defined as visit duration < 100 days, poor outcome is defined as visit duration $\geq$ 100 days} \label{tab:good_outcome_poor_outcome_origi}
\end{table}